醫療保健資料貨幣化市場規模、佔有率和成長分析:按資料類型、模型、最終用戶、部署模式和地區分類-2026-2033年產業預測
市場調查報告書
商品編碼
2048634

醫療保健資料貨幣化市場規模、佔有率和成長分析:按資料類型、模型、最終用戶、部署模式和地區分類-2026-2033年產業預測

Healthcare Data Monetization Market Size, Share, and Growth Analysis, By Data Type (Clinical Data, Claims Data), By Model (Data as a Service (DaaS), Analytics-as-a-Service), By End-User, By Deployment, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球醫療保健數據貨幣化市場價值為 35.2 億美元,預計到 2025 年將成長至 40.6 億美元,到 2033 年將成長至 128.5 億美元,在預測期(2026-2033 年)內複合年成長率為 15.32%。

在結構化和非結構化臨床數據湧入以及互通性的推動下,醫療保健數據貨幣化的格局正在迅速演變。這項轉變正透過合法的數據聚合、匿名化和商業化,將病患記錄和醫療設備數據轉化為寶貴的資產,目標客戶包括保險公司、研究人員和供應商。這種貨幣化模式對醫療經濟學至關重要,它能夠最佳化醫療路徑並促進創新。隨著電子健康記錄 (EHR) 的普及和雲端分析技術的進步,市場正日趨成熟。先進的分析技術和人工智慧對於將數據轉化為預測模型至關重要,從而提升了數據資產的需求和價值。聯邦學習和合成資料也蘊藏著機會。這些技術在保護隱私的同時,促進了機構間的合作,從而創造了擴充性的收入來源並緩解了監管方面的挑戰。

全球醫療保健數據貨幣化市場的促進因素

資料聚合平台的出現為各機構提供了一個絕佳的機會,可以將臨床記錄、理賠資料、影像結果和病患報告結局(PRO)等多種資料類型整合到一個統一的資料庫中。這種整合提高了數據資產的相關性和效用,使其對潛在買家更具吸引力。它還有助於創建強大且可互通的解決方案,同時簡化資料協調流程,最大限度地減少為商業化準備資料集所需的工作量。此外,這些平台使更多醫療服務提供者和仲介業者能夠更快地進入市場,從而刺激整體市場參與和創新。

全球醫療保健數據貨幣化市場的限制因素

隱私框架的多樣性和嚴格的資料保護條例給尋求將醫療保健資料集貨幣化的機構帶來了巨大的合規挑戰。這些要求要求在共用或出售商業資料集之前,必須進行廣泛的匿名化、同意管理和管治流程。因此,企業面臨著監管不一致帶來的重大營運困難和法律不確定性,而用於應對這些複雜性的資源有限,這可能會阻礙其市場准入。此外,維護病患信任和遵守監管義務的需求進一步增加了資料市場交易準備工作的成本和資源需求。

全球醫療保健數據貨幣化市場趨勢

全球醫療保健數據貨幣化市場正經歷著向價值醫療模式的顯著轉變。相關人員正策略性地利用病患預後數據,創造新的商業性和合作機會。各機構優先考慮縱向健康記錄和真實世界數據(REW),以增強醫療服務的連貫性、風險管理和人群健康策略。供應商現在能夠基於臨床結果和效率的提升有效地推廣數據產品,從而推動合約和價值共用模式的創新。這一趨勢體現了數據商業化的永續發展模式,有助於提高醫療服務的品質和經濟可預測性,並為各機構在日益數據主導的環境中取得成功奠定基礎。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球醫療保健數據貨幣化市場規模:按數據類型分類

  • 臨床數據
  • 計費數據
  • 患者產生的數據
  • 基因組數據

全球醫療保健數據貨幣化市場規模:按模型分類

  • Data as a Service(DaaS)
  • Analytics-as-a-Service
  • 授權

全球醫療保健數據貨幣化市場規模:按最終用戶分類

  • 製藥公司
  • 保險公司
  • 醫療設備製造商
  • 研究機構

全球醫療保健數據貨幣化市場規模:按部署模式分類

  • 基於雲端的
  • 現場

全球醫療保健數據貨幣化市場規模:按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要公司簡介

  • IQVIA Holdings
  • Optum(UnitedHealth)
  • IBM Watson Health
  • Veeva Systems
  • Health Catalyst
  • Inovalon Holdings
  • Truven Health Analytics(IBM)
  • Cotiviti
  • DST Systems(SS&C)
  • Change Healthcare
  • Advisory Board Company
  • ZS Associates
  • Palantir Technologies
  • Komodo Health
  • Flatiron Health(Roche)
  • Tempus Labs
  • Clarify Health
  • Arcadia Healthcare
  • HSBlox
  • Redox Engine

結論與建議

簡介目錄
Product Code: SQMIG35G2399

Global Healthcare Data Monetization Market size was valued at USD 3.52 Billion in 2024 and is poised to grow from USD 4.06 Billion in 2025 to USD 12.85 Billion by 2033, growing at a CAGR of 15.32% during the forecast period (2026-2033).

The healthcare data monetization landscape is rapidly evolving, propelled by an influx of structured and unstructured clinical data along with enhanced interoperability. This transformation turns patient records and device data into valuable assets through lawful aggregation, de-identification, and commercialization aimed at payers, researchers, and vendors. Such monetization is becoming integral to health economics, enabling better care pathways and fostering innovation. The market has matured with the widespread adoption of electronic health records and advancements in cloud analytics. Advanced analytics and artificial intelligence are critical in transforming data into predictive models, increasing demand and valuations for data assets. Opportunities also lie in federated learning and synthetic data, which promote privacy while facilitating cross-institutional collaborations, thereby generating scalable revenue streams and easing regulatory challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Healthcare Data Monetization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Healthcare Data Monetization Market Segments Analysis

Global healthcare data monetization market is segmented by data type, model, end-user, deployment and region. Based on data type, the market is segmented into Clinical Data, Claims Data, Patient-Generated Data and Genomic Data. Based on model, the market is segmented into Data as a Service (DaaS), Analytics-as-a-Service and Licensing. Based on end-user, the market is segmented into Pharmaceutical Companies, Insurance Companies, Medical Device Firms and Research Institutions. Based on deployment, the market is segmented into Cloud-Based and On-Premise. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Healthcare Data Monetization Market

The emergence of data aggregators has opened up significant opportunities for organizations to consolidate diverse data types, such as clinical records, claims, imaging results, and patient-reported outcomes into a unified repository. This consolidation enhances the relevance and usability of data assets, making them more appealing to potential buyers. It facilitates the creation of robust, interoperable solutions while streamlining the data harmonization process, which minimizes the effort required to prepare datasets for monetization. Additionally, these platforms enable a broader range of healthcare providers and intermediaries to enter the market more rapidly, thus increasing overall participation and innovation.

Restraints in the Global Healthcare Data Monetization Market

The diverse landscape of privacy frameworks and stringent data protection regulations poses considerable compliance challenges for organizations seeking to monetize health-related datasets. These requirements necessitate extensive de-identification, consent management, and governance processes before any commercial datasets can be shared or sold. As a result, companies face significant operational difficulties and legal uncertainties stemming from inconsistent regulations, which can hinder their efforts to enter the market due to limited available resources to navigate these complexities. Additionally, the need to uphold patient trust and adhere to regulatory mandates further escalates the costs and resource demands associated with preparing data for market transactions.

Market Trends of the Global Healthcare Data Monetization Market

The Global Healthcare Data Monetization market is witnessing a significant trend towards value-based care integration, where stakeholders are strategically leveraging patient outcome data to drive new commercial and collaborative opportunities. By prioritizing longitudinal health records and real-world evidence, organizations enhance care coordination, risk management, and population health strategies. Vendors are now able to effectively market their data products based on clinical outcomes and efficiency gains, prompting innovation in contractual agreements and value-sharing models. This trend reflects a sustainable approach to data commercialization, fostering quality improvement and economic predictability in healthcare delivery, positioning organizations for future success in an increasingly data-driven environment.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Healthcare Data Monetization Market Size by Data Type & CAGR (2026-2033)

  • Market Overview
  • Clinical Data
  • Claims Data
  • Patient-Generated Data
  • Genomic Data

Global Healthcare Data Monetization Market Size by Model & CAGR (2026-2033)

  • Market Overview
  • Data as a Service (DaaS)
  • Analytics-as-a-Service
  • Licensing

Global Healthcare Data Monetization Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical Companies
  • Insurance Companies
  • Medical Device Firms
  • Research Institutions

Global Healthcare Data Monetization Market Size by Deployment & CAGR (2026-2033)

  • Market Overview
  • Cloud-Based
  • On-Premise

Global Healthcare Data Monetization Market Size & CAGR (2026-2033)

  • North America (Data Type, Model, End-User, Deployment)
    • US
    • Canada
  • Europe (Data Type, Model, End-User, Deployment)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Data Type, Model, End-User, Deployment)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Data Type, Model, End-User, Deployment)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Data Type, Model, End-User, Deployment)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • IQVIA Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Optum (UnitedHealth)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IBM Watson Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Veeva Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Health Catalyst
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inovalon Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Truven Health Analytics (IBM)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cotiviti
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DST Systems (SS&C)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Change Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advisory Board Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZS Associates
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Palantir Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Komodo Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flatiron Health (Roche)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tempus Labs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clarify Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arcadia Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HSBlox
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Redox Engine
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations